Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting.
- DOI
- 10.1038/s41598-023-36623-1
- Published
- 2023 Jun 13
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-023-36623-1,
title = {Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting.},
author = {Belaroussi Y and Bouteiller F and Bellera C and Pasquier D and Perol M and Debieuvre D and Filleron T and Girard N and Schott R and Mathoulin-Pélissier S and Martin AL and Cousin S},
year = {2023},
journal = {Scientific reports},
doi = {10.1038/s41598-023-36623-1},
url = {https://doi.org/10.1038/s41598-023-36623-1}
}RIS
TY - JOUR TI - Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting. AU - Belaroussi Y AU - Bouteiller F AU - Bellera C AU - Pasquier D AU - Perol M AU - Debieuvre D AU - Filleron T AU - Girard N AU - Schott R AU - Mathoulin-Pélissier S AU - Martin AL AU - Cousin S PY - 2023 JO - Scientific reports DO - 10.1038/s41598-023-36623-1 UR - https://doi.org/10.1038/s41598-023-36623-1 ER -
APA
Y, B., F, B., C, B., D, P., M, P., D, D., T, F., N, G., R, S., S, M., AL, M., & S, C. (2023). Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting.. Scientific reports. https://doi.org/10.1038/s41598-023-36623-1
Source records
- pubmed · retrieved 2026-09-26T13:54:39.271Z